| Sabina Lynn Wayment, PHARMD | |
|
5305 S 1900 W, Roy, UT 84067-2906 | |
| (801) 825-5648 | |
| (801) 825-5728 |
| Full Name | Sabina Lynn Wayment |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 5305 S 1900 W, Roy, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326614686 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10098680 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sabina Lynn Wayment, PHARMD 5305 S 1900 W, Roy, UT 84067-2906 Ph: (801) 825-5648 | Sabina Lynn Wayment, PHARMD 5305 S 1900 W, Roy, UT 84067-2906 Ph: (801) 825-5648 |
News Archive
A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to hemostasis for patients receiving cardiac catherization. The findings indicate a faster approach to removing the compression band used during the procedure, without compromising safety.
"The reason our skin becomes more leathery and thick as we age might be due to a loss of elasticity in the cells," says Igor Sokolov of Clarkson University, who presented his latest research findings during a session on bio-imaging techniques at the Annual American Physical Society (APS) March meeting in Montreal.
There is no consensus on when to introduce cardioprotective treatment in patients with Becker muscular dystrophy (BMD), and practice varies widely.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from two Phase 2 studies evaluating investigational all-oral regimens containing the nucleotide analog polymerase inhibitor sofosbuvir (SOF) for the treatment of chronic hepatitis C virus (HCV) infection.
Today, the U.S. Food and Drug Administration issued a new report titled, "Resiliency Roadmap for FDA Inspectional Oversight," outlining the agency's inspectional activities during the COVID-19 pandemic and its detailed plan to move toward a more consistent state of operations, including the FDA's priorities related to this work going forward.
› Verified 1 days ago
Linh Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5554 S 1900 W, Roy, UT 84067 Phone: 801-614-1263 | |
Dr. Amanda K Laraway, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5554 S 1900 W, Roy, UT 84067 Phone: 801-614-1263 | |
Megan Smedley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5554 S 1900 W, Roy, UT 84067 Phone: 801-614-1263 | |
Joseph F Burum, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4815 S 3500 W, Roy, UT 84067 Phone: 801-985-7011 | |
Kenneth E Adams, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5673 S 1900 W, Roy, UT 84067 Phone: 801-825-8021 | |
Inger Christensen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5554 S 1900 W, Roy, UT 84067 Phone: 801-614-1263 Fax: 801-614-1266 | |
Jeremy Kim Burtenshaw, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5450 S 2150 W, Roy, UT 84067 Phone: 801-678-2971 |